Trial · NCT01840072
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| A Combination of Death Within 14 Days After Randomization and Major Disability at 14 Days or at Hospital Discharge if Earlier Than 14 Days. | Usual Care | 681 | participants | ||
| A Combination of Death Within 14 Days After Randomization and Major Disability at 14 Days or at Hospital Discharge if Earlier Than 14 Days. | Active Antihypertensive Treatment | 683 | participants | ||
| A Combination of All-cause Mortality and Major Disability at the 3-month Post-treatment Follow-up. | Usual Care | 502 | Participants | ||
| A Combination of All-cause Mortality and Major Disability at the 3-month Post-treatment Follow-up. | Active Antihypertensive Treatment | 500 | Participants | ||
| Mortality | Active Antihypertensive Treatment | 68 | participants | ||
| Mortality | Usual Care | 54 | participants | ||
| Recurrent Stroke | Active Antihypertensive Treatment | 28 | participants | ||
| Recurrent Stroke | Usual Care | 43 | participants | ||
| Other Vascular Events | Usual Care | 59 | participants | ||
| Other Vascular Events | Active Antihypertensive Treatment | 48 | participants | ||
| Long-term Neurological and Functional Status | Usual Care | 1.0 | Inter-Quartile Range 1.0 to 3.0 | Score on modified Rankin scale | |
| Long-term Neurological and Functional Status | Active Antihypertensive Treatment | 1.0 | Inter-Quartile Range 1.0 to 3.0 | Score on modified Rankin scale | |
| Cognitive Function (the Mini-Mental State Examination) | Usual Care | 26 | Inter-Quartile Range 22 to 29 | MMSE score | |
| Cognitive Function (the Mini-Mental State Examination) | Active Antihypertensive Treatment | 26 | Inter-Quartile Range 22 to 29 | MMSE score | |
| Cognitive Function (Montreal Cognitive Assessment) | Usual Care | 22 | Inter-Quartile Range 18 to 26 | MoCA score | |
| Cognitive Function (Montreal Cognitive Assessment) | Active Antihypertensive Treatment | 22 | Inter-Quartile Range 18 to 26 | MoCA score |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01840072/results